Drug Type Small molecule drug |
Synonyms Atorvastatin/glimepiride, Glimepiride/atorvastatin |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), KATP channels blockers, SUR modulators(Sulfonylurea receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC66H70CaF2N4O10 |
InChIKeySSZRLAUYRCMGSP-MNSAWQCASA-N |
CAS Registry134523-03-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 3 | MY | - | |
Diabetes Mellitus, Type 2 | Phase 3 | MX | - | |
Diabetes Mellitus, Type 2 | Phase 3 | PH | - | |
Diabetes Mellitus, Type 2 | Phase 3 | RU | - | |
Diabetes Mellitus, Type 2 | Phase 3 | KR | - | |
Diabetes Mellitus, Type 2 | Phase 3 | TH | - |